African countries heavily rely on foreign suppliers for their drugs and vaccines, with as much as 90% of drugs and 99% of vaccines being imported. This reliance became apparent during the COVID-19 pandemic when access to essential medicines and vaccines proved challenging for many African nations.
Lamia Tazi, the CEO of Sothema, Morocco’s largest pharmaceutical company, advocates for the development of Africa’s own pharmaceutical industry. Tazi emphasizes the need to ensure an adequate supply of critical treatments. In a recent interview with Bloomberg, she discussed various challenges and opportunities facing the continent.
Tazi identifies Western pharmaceutical companies‘ focus on their domestic markets as a significant challenge. This limited attention leaves Africa with restricted access to necessary medicines and vaccines. Consequently, she highlights the pressing need for Africa to cultivate its own pharmaceutical capacity.
Intellectual property protection poses another obstacle. Due to financial constraints, several African countries resort to generic versions of patented drugs. However, patent laws often prohibit the production of generics without the patent holder’s consent, making it difficult for these nations to meet their needs.
Despite the challenges, Tazi believes Africa has opportunities to establish its pharmaceutical industry. The continent’s growing population, accompanied by a rising middle class, creates a expanding market for medicines and vaccines. Additionally, Africa possesses skilled scientists and engineers who can contribute to the development of a homegrown pharmaceutical sector.
Tazi emphasizes the importance of increased governmental support for the pharmaceutical industry, including funding for research and development, as well as the creation of a favorable regulatory environment. She also calls upon international organizations, such as the World Health Organization, to play a more significant role in assisting Africa’s pharmaceutical industry development.
Tazi concludes by emphasizing the significance of Africa having its own pharmaceutical industry, stating that it is a matter of health security.
James Gorman to Step Down as CEO of Morgan Stanley: Who Will Replace Him?
